Alpha Profiles · Company Profile

Spyre Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/spyre-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: SYRE
Verification: Partially verified
Last reviewed: 2026-10-08T04:45:32.948331+00:00

Overview

Alpha's canonical identity and public leadership record for Spyre Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

Cameron Turtle, D.Phil.

Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001636282-26-000039Apr 10, 2026

Heidy King-Jones

Chief Legal Officer and Corporate Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001636282-26-000039Apr 10, 2026

Not provided in excerpt

Chief Commercial Officer

State: confirmed
Effective: From Feb 19, 2026
Confidence: 94%
Evidence: SYRE 10-K executive officersFeb 19, 2026

Scott Burrows

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001636282-26-000039Apr 10, 2026

Sheldon Sloan

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001636282-26-000039Apr 10, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 8, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.